Synergistic activity of a short lipidated antimicrobial peptide (lipoAMP) and colistin or tobramycin against Pseudomonas aeruginosa from cystic fibrosis patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Synergistic activity of a short lipidated antimicrobial peptide (lipoAMP) and colistin or tobramycin against Pseudomonas aeruginosa from cystic fibrosis patients

Published:2016 Issue:1 Volume:7 Page:148-156
ISSN:2040-2503
Container-title:MedChemComm
language:en
Short-container-title:Med. Chem. Commun.

Author:

de Gier Martin G.¹²³⁴⁵,Bauke Albada H.⁶⁷⁸⁹¹⁰,Josten Michaele¹¹¹²¹³¹⁴⁹,Willems Rob¹⁵²³⁴⁵,Leavis Helen¹⁵²³⁴⁵,van Mansveld Rosa¹⁵²³⁴⁵,Paganelli Fernanda L.¹⁵²³⁴⁵,Dekker Bertie¹⁵²³⁴⁵,Lammers Jan-Willem J.¹²³⁴⁵,Sahl Hans-Georg¹¹¹²¹³¹⁴⁹,Metzler-Nolte Nils⁶⁷⁸⁹^ORCID

Affiliation:

1. Department of Pulmonology

2. University Medical Center Utrecht

3. University of Utrecht

4. Utrecht

5. The Netherlands

6. Inorganic Chemistry I – Bioinorganic Chemistry

7. Ruhr University Bochum

8. Bochum

9. Germany

10. The Center for Nanoscience and Nanotechnology

11. Institute of Medical Microbiology, Immunology, and Parasitology

12. Pharmaceutical Microbiology Section

13. University of Bonn

14. Bonn

15. Department of Medical Microbiology

Abstract

Synergistic effects between a lipoAMP and colistin against clinical P. aeruginosa strains isolated from cystic fibrosis patients are described.

Publisher

Royal Society of Chemistry (RSC)

Subject

Pharmaceutical Science,Biochemistry,Drug Discovery,Molecular Medicine,Pharmacology,Organic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2016/MD/C5MD00373C

Reference67 articles.

1. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis

2. Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis

3. Molecular Epidemiology and Dynamics of Pseudomonas aeruginosa Populations in Lungs of Cystic Fibrosis Patients

4. Pseudomonas aeruginosabiofilm infections in cystic fibrosis: insights into pathogenic processes and treatment strategies

5. Cystic fibrosis: a mucosal immunodeficiency syndrome

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complementary Activities of Host Defence Peptides and Antibiotics in Combating Antimicrobial Resistant Bacteria;Antibiotics;2023-10-06

2. Antimicrobial Peptide Synergies for Fighting Infectious Diseases;Advanced Science;2023-07-05

3. Improving the Management and Treatment of Diabetic Foot Infection: Challenges and Research Opportunities;International Journal of Molecular Sciences;2023-02-15

4. Synergistic Activity of Repurposed Peptide Drug Glatiramer Acetate with Tobramycin against Cystic Fibrosis Pseudomonas aeruginosa;Microbiology Spectrum;2022-08-31

5. Antimicrobial Peptides as an Alternative for the Eradication of Bacterial Biofilms of Multi-Drug Resistant Bacteria;Pharmaceutics;2022-03-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3